Results 141 to 150 of about 94,270 (218)

Transcriptomic and Proteomic Analyses Identify THBS2, VWF, NFASC, and AKR1B10 as Diagnostic Biomarkers for Advanced Fibrosis in NAFLD. [PDF]

J Inflamm Res
Ding S, Liu Y, Liu Z, Chu F, Lu B, Xu L.
europepmc   +1 more source

3,3′,4,5′‐Tetramethoxy‐trans‐stilbene Alleviates Metabolic Dysfunction‐Associated Steatotic Liver Disease

eFood, Volume 7, Issue 4, August 2026.
3,3′,4,5′‐Tetramethoxy‐trans‐stilbene alleviates hepatic insulin resistance and metabolic dysfunction‐associated steatotic liver disease, through the activation of IRS/PI3K/Akt/GSK3β/GS and Nrf2/HO‐1 pathways, in diet‐induced obese mice. The figure was created with MedPeer (medpeer.cn).
Qiaowen Deng, Yuehan Wang, Feiyang Zheng, Manqin Fu, Chumin Zhong, Dharmani Devi Murugan, Wai San Cheang   +6 more
wiley   +1 more source

The Association Between Dietary Acid Load and Non-Alcoholic Fatty Liver Disease. [PDF]

Food Sci Nutr
Homayounfar N, Rivaz R, Sedghi Z, Seifi N.   +3 more
europepmc   +1 more source

Metabolic dysfunction–associated steatotic liver disease and cardiovascular disease: Emerging insights into the liver–heart axis

Journal of Diabetes Investigation, EarlyView.
Seung‐Hwan Lee
wiley   +1 more source

Association Between Dietary Advanced Glycation End Products (AGEs) and Pancreatic Fat Accumulation: Evidence From a Case–Control Study

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 4, July 2026.
Higher dietary intake of Advanced Glycation End Products (AGEs) was associated with higher odds of pancreatic steatosis in this case–control sample of gallstone patients. ABSTRACT Background Pancreatic steatosis (PS) is a metabolic condition associated with obesity, insulin resistance, and fatty liver disease.
Mohammad Reza Shahparvari, Zahra Yari, Maedeh Chegini, Mohammad Bahrizadeh, Amir Sadeghi, Azita Hekmatdoost   +5 more
wiley   +1 more source

Urea cycle dysregulation and arginine pathways in the pathogenesis of NAFLD and NASH (Review). [PDF]

Int J Mol Med
Zhu B, Wang C, Liu P, Qu Z, Qi R, Chen S, Niu H.   +6 more
europepmc   +1 more source

Frequency of Insulin Resistance in Overweight Patients With Metabolic‐Associated Fatty Liver Disease (MAFLD) at a Tertiary Healthcare Centre in Bangladesh

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 4, July 2026.
Among overweight, non‐diabetic MAFLD patients at a Bangladeshi tertiary centre, 60% had insulin resistance (median HOMA‐IR: 2.85). Acanthosis nigricans significantly correlated with higher HOMA‐IR (5.79 vs. 2.89). No significant correlation existed between HOMA‐IR and BMI, METS‐IR, or TG/HDL‐c ratio.
Md. Mohiuddin Rozaik, Md. Kawsar Uddin, Syed Azmal Mahmood, Sadia Islam Sukonna, Tasnim Nafian, Kazi Ali Aftab, Khaled Mahbub Murshed, Md Abul Kalam Azad   +7 more
wiley   +1 more source

Microalgae Oil Attenuates Liver Fat Deposition in NAFLD via Modulation of Anti-Lipogenic Genes and Insulin Signaling Pathways in HFD Mice. [PDF]

Food Sci Nutr
AlQahtani A, Wang M, Liu L, Ran L, Liu C, Liang Y, Yu J, Wu Y, Guan Q.   +8 more
europepmc   +1 more source

Adherence to UK Dietary Reference Values and Lower Odds of Non‐Alcoholic Fatty Liver Disease: A Secondary Analysis of a Case–Control Study

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 4, July 2026.
Higher adherence to the UK‐DRV index—reflecting greater intake of fibre, fruits, vegetables, and fish, and lower intake of sugars and saturated fats—is associated with lower odds of NAFLD in Iranian adults, though causality cannot be inferred from this case–control design.
Mehdi Khakian, Sanaz Jamshidi, Mitra Kazemi Jahromi, Ebrahim Mokhtari, Setareh Alibakhshi, Niloufar Saber, Reza Sadeghi, Ammar Salehi‐sahlabadi, Elham Sobhrakhshankhah, Farshad Teymoori, Parvin Mirmiran, Hossein Farhadnejad   +11 more
wiley   +1 more source

Single-Nucleotide Polymorphisms in Genes Associated with Mitochondrial and DNA Damage Response Modulate the Risk of Non-Alcoholic Fatty Liver Disease in Humans. [PDF]

Int J Mol Sci
Ziółkowska S, Kosmalski M, Kołodziej Ł, Jarmusz K, Ejsmont M, Pietras T, Jabłkowska A, Jabłkowski M, Szemraj J, Czarny P.   +9 more
europepmc   +1 more source